2007 Conference Publication Live donor characteristics over the last 15 yearsKaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
2007 Conference Publication Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markersRajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers. 46th ASMR National Scientific Conference, Katoomba, N.S.W., Australia, 11-13 November 2007. |
2007 Conference Publication The molecular and cellular changes associated with ageing and disease in the kidneyPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2007). The molecular and cellular changes associated with ageing and disease in the kidney. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8-12 September, 2007. |
2007 Journal Article The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantationHourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399. |
2007 Conference Publication The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapyLi, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia: |
2007 Conference Publication Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipientKaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
2007 Journal Article Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factorsOrazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x |
2007 Journal Article Evaluation of renal function: CARI guidelinesJohnson, David W. (2007). Evaluation of renal function: CARI guidelines. Australian Family Physician, 36 (1-2), 46-46. |
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x |
2007 Conference Publication Intravenous versus oral iron supplementation in peritoneal dialysis patientsJohnson, David W. (2007). Intravenous versus oral iron supplementation in peritoneal dialysis patients. The 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25-29 August, 2006. Milton, Ontario: Multimed Inc.. |
2007 Journal Article Update for GPs on the management of mild to moderate renal impairment.Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34. |
2006 Journal Article Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell linesMorais, Christudas, Pat, Betty, Gobe, Glenda, Johnson, David W. and Healy, Helen (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrology Dialysis Transplantation, 21 (12), 3377-3388. doi: 10.1093/ndt/gfl543 |
2006 Journal Article Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipientsArmstrong, Kirsten, Rakhit, Dhrubo, Jeffriess, Leanne, Johnson, David, Leano, Rodel, Prins, John, Garske, Luke, Marwick, Thomas and Isbel, Nicole (2006). Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clinical Journal of The American Society of Nephrology, 1 (6), 1275-1283. doi: 10.2215/CJN.00210106 |
2006 Journal Article A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patientsJohnson, David W., Wong, Jennifer, Wiggins, Kathryn J., Kirwan, Robyn, Griffin, Anthony, Preston, John, Wall, Daryl, Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Hawley, Carmel M. and Nicol, David L. (2006). A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients. American Journal of Kidney Diseases, 48 (5), 812-821. doi: 10.1053/j.ajkd.2006.08.010 |
2006 Journal Article Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysisTeigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987 |
2006 Journal Article Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney diseaseRakhit, D. J., Marwick, T. H., Armstrong, K. A., Johnson, D. W., Leano, R. and Isbel, N. M. (2006). Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart, 92 (10), 1402-1408. doi: 10.1136/hrt.2005.074393 |
2006 Journal Article Novel renoprotective actions of erythropoietin: New uses for an old hormoneJohnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x |
2006 Journal Article Przewlekła choroba nerek: Uaktualnienie postępowaniaJohnson, David W. and Usherwood, Tim (2006). Przewlekła choroba nerek: Uaktualnienie postępowania. Lekarz Rodzinny (7-8 (107-108)), 802-810. |
2006 Journal Article A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis PatientsKaisar, Mohammed O., Wiggins, Kathryn J., Sturtevant, Joanne M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Bofinger, Andrew, Petrie, James J.B. and Johnson, David W. (2006). A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients. American Journal of Kidney Diseases, 47 (5), 809-814. doi: 10.1053/j.ajkd.2006.01.014 |
2006 Journal Article In replyMathew, Timothy H., Jones, Graham and Johnson, David (2006). In reply. Medical Journal of Australia, 184 (9), 476-477. doi: 10.5694/j.1326-5377.2006.tb00330.x |